DR. BABASAHEB AMBEDKAR OPEN UNIVERSITY B.ED ADMISSION JAHERAT 2019.
INDIVIDUAL CHARACTERISTICS AND MESOTHELIOMA SURVIVAL TUMOR LOCATION STAGE OF DISEASE MESOTHELIOMA CELL TYPE AGE AT DIAGNOSIS AND OVERALL HEALTH GENDER RACE/ETHNICITY A 2018 ANALYSIS OF 888 CASES IN THE NATIONAL MESOTHELIOMA VIRTUAL BANK COHIRT IDENTIFIED MEDIAN OVERALL SURVIVAL OF 15 MONTHS, ON AVERAGE FOR PLEURAL AND PERITONEAL PATIENTS COMBINED.
THE MOST IMPORTANT FACTORS ASSOCIATED WITH BETTER SUSVIVAL WERE AGE.
FEMALE GENDER EPITHELIOID CELL TYPE ,STAGE 1 DISEASE,PERITONEAL OCCURRENCE AND TREATMENT COMBINING SURGERY WITH CHEMOTHRAPY .MESOTHELIOMA TUMOR LOCATION THERE ARE FOUR TYPES OF MESOTHELIOMA, AND THE SITE WHERE THE CANCER ORIGINATES AFFECTS PATIENT OUTCOMES. SURVIVAL IS SIGNIFICANTLY BETTER FOR PERITONEAL PATIENTS. ABOUT 40 PERCENTS SURVIVE AT LEAST ONE YEAR.
DR. BABASAHEB AMBEDKAR OPEN UNIVERSITY B.ED ADMISSION JAHERAT - 2019.
Click Here View And Download
Click Here to Website
Click Here To Pustika
THIS COMPARES TO A MEDIAN SURVIVAL OF LESS THAN 12 MONTHS FOR PATIENTS WITH PLEURAL TUMORS. IN SELECT STUDIES, HEATED CHEMOTHERAPY HAS BOOSTED PERITONEAL SURVIVAL TO ETWEEN 40 AND 92 MONTHS. A 2015 META -STUDY PUBLISHED IN TRANSLATIONAL ONCOLOGY ANALYZED 20 YEAR OF DATA, COLLECTED FROM 1992 TO 2012. THE FIVE YEAR SURVIVAL RATE FOR PERITONEAL MESTHELIOMA PATIENTS WAS MORE THAN FIVE - TIMES HIGHER THAN THE RATE FOR PLEURAL PATIENTS.
INDIVIDUAL CHARACTERISTICS AND MESOTHELIOMA SURVIVAL TUMOR LOCATION STAGE OF DISEASE MESOTHELIOMA CELL TYPE AGE AT DIAGNOSIS AND OVERALL HEALTH GENDER RACE/ETHNICITY A 2018 ANALYSIS OF 888 CASES IN THE NATIONAL MESOTHELIOMA VIRTUAL BANK COHIRT IDENTIFIED MEDIAN OVERALL SURVIVAL OF 15 MONTHS, ON AVERAGE FOR PLEURAL AND PERITONEAL PATIENTS COMBINED.
THE MOST IMPORTANT FACTORS ASSOCIATED WITH BETTER SUSVIVAL WERE AGE.
FEMALE GENDER EPITHELIOID CELL TYPE ,STAGE 1 DISEASE,PERITONEAL OCCURRENCE AND TREATMENT COMBINING SURGERY WITH CHEMOTHRAPY .MESOTHELIOMA TUMOR LOCATION THERE ARE FOUR TYPES OF MESOTHELIOMA, AND THE SITE WHERE THE CANCER ORIGINATES AFFECTS PATIENT OUTCOMES. SURVIVAL IS SIGNIFICANTLY BETTER FOR PERITONEAL PATIENTS. ABOUT 40 PERCENTS SURVIVE AT LEAST ONE YEAR.
DR. BABASAHEB AMBEDKAR OPEN UNIVERSITY B.ED ADMISSION JAHERAT - 2019.
Click Here View And Download
Click Here to Website
Click Here To Pustika
THIS COMPARES TO A MEDIAN SURVIVAL OF LESS THAN 12 MONTHS FOR PATIENTS WITH PLEURAL TUMORS. IN SELECT STUDIES, HEATED CHEMOTHERAPY HAS BOOSTED PERITONEAL SURVIVAL TO ETWEEN 40 AND 92 MONTHS. A 2015 META -STUDY PUBLISHED IN TRANSLATIONAL ONCOLOGY ANALYZED 20 YEAR OF DATA, COLLECTED FROM 1992 TO 2012. THE FIVE YEAR SURVIVAL RATE FOR PERITONEAL MESTHELIOMA PATIENTS WAS MORE THAN FIVE - TIMES HIGHER THAN THE RATE FOR PLEURAL PATIENTS.
0 Komentar untuk "DR. BABASAHEB AMBEDKAR OPEN UNIVERSITY B.ED ADMISSION JAHERAT - 2019"